Thermo Fisher Scientific Inc. TMO

NYSEHealth TechnologyUnited States

$700.22+0.78 (+0.11%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 689.79701.97
52-week range: 435.27727.56

Financial health

– / 5

Analyst view · 29 firms

Buy24 buy · 4 hold · 1 sell

Avg. target $766.12 (+9.4%)

Prices may be delayed and are for informational purposes only - not investment advice.

Thermo Fisher Scientific Inc. TMO

NYSEHealth TechnologyUnited States

$700.22+0.78 (+0.11%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 689.79701.97
52-week range: 435.27727.56

Financial health

– / 5

Analyst view · 29 firms

Buy24 buy · 4 hold · 1 sell

Avg. target $766.12 (+9.4%)

Valuation from filings

Calculated from the tables below and the current price ($700.22) · LTM · 2026/9 · 2026-09-26

P/E: 36.95EPS $18.95
P/B: 4.75BV/share $147.34
P/S: 5.50Sales/share $127.40
Return on equity: 12.9%Net income / equity
Net margin: 14.9%Operating margin 17.9%
Free cash flow yield: 2.9%Free cash flow / market cap

Revenue and net income

Fiscal year · $ billions · net margin below

RevenueNet Income

Financial statements

$ millions · Under each value: change against a year earlier

Upgrade to MakklerPRO to see every row.Upgrade to MakklerPRO

Fiscal year	2021	2022	2023	2024	2025	LTM
Income Statement
Revenue	39,211	44,915+15%	42,857-5%	42,8790%	44,556+4%	47,351
Operating expenses
Operating Income
Pre-tax income
Income tax (expense) / benefit
Net Income	7,725	6,950-10%	5,995-14%	6,335+6%	6,704+6%	7,072
Earnings per share ($)
Margins
Operating margin
Net margin

Taken from the company's own 10-K and 10-Q filings via the SEC's XBRL data service. The "LTM" column is the last completed fiscal year plus the current year to date, minus the same period a year earlier. Lines a company tags with a non-standard label are left blank rather than filled with an approximation. Not investment advice.